Saturday, December 20, 2025 | 09:28 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Triple jeopardy in health

This is not all. Not only are we not conserving the existing stock of medicines, the drug pipeline for new antibiotics is drying up, or has done so already

drugs, medical, medicine
premium

Sunita Narain
We now know that antibiotics — medicines that we take in times of grave health dangers — are getting increasingly ineffective in killing the microbes that make us ill. This silent pandemic of antimicrobial resistance (AMR) is caused by overuse and misuse of antibiotics, which has made pathogens mutate and build defence mechanisms against these drugs. Today, AMR is taking lives. Estimates say that the inability of life-saving medicines to work led to some five million deaths in 2019.

This is not all. Not only are we not conserving the existing stock of medicines, the drug pipeline for new antibiotics is
Disclaimer: These are personal views of the writer. They do not necessarily reflect the opinion of www.business-standard.com or the Business Standard newspaper